Latest in News & Research

a

Is Tirbanibulin Effective for Treating Actinic Keratosis?

Improvement seen in Skindex-16 quality-of-life scores in symptoms, emotions, functioning domains at week 8 with tirbanibulin

By Dermsquared Editorial Team | May 24, 2023

Do Patients With Melasma Have Lower Levels of Serum Vitamin D?

Average serum calcidiol 33.8 ± 15.8 ng/mL seen in patients with melasma versus 36.8 ± 15.8 ng/mL in other dermatology patients

By Dermsquared Editorial Team | May 24, 2023

Microdosed Incisional Clindamycin Cuts SSI After Skin Cancer Surgery

Significantly fewer lesions receiving microdosed clindamycin, flucloxacillin required postoperative systemic antibiotics

By Elana Gotkine (HealthDay News) | May 24, 2023

JYNNEOS Vaccine Seems Effective for Preventing Mpox

Two-dose series offers better protection, with vaccine effectiveness of 66.0 percent compared with 35.8 percent for one-dose

By Elana Gotkine (HealthDay News) | May 19, 2023

Is Oxymetazoline Effective for Persistent Facial Erythema of Rosacea?

Clinician Erythema Assessment success rate significantly higher after oxymetazoline treatment versus vehicle

By Dermsquared Editorial Team | May 19, 2023

Hyaluronic Acid-Based Filler Produces Midface Volume Restoration

Benefit persists for 540 days in some individuals, even without retouch

By Dermsquared Editorial Team | May 19, 2023

Domestic Abuse Tied to Higher Risk for New Atopic Disease

Higher risk seen for asthma, atopic eczema, and allergic rhinoconjunctivitis

By Lori Solomon (HealthDay News) | May 19, 2023

Brepocitinib Beneficial for Moderate-to-Severe Psoriatic Arthritis

Significantly greater ACR20 response rates seen at week 16 for 30 and 60 mg QD versus placebo; response maintained or improved at 52 weeks

By Elana Gotkine (HealthDay News) | May 18, 2023

CDC Warns That Mpox Could Make a Summer Return

An outbreak in Chicago of the virus formerly called monkeypox has public health officials on edge

By HealthDay News | May 16, 2023

People With Alopecia Have Higher Risk for Inflammatory Arthritis

Increased risk seen for psoriatic and rheumatoid arthritis, and ankylosing spondylitis

By Lori Solomon (HealthDay News) | May 15, 2023

Skin Lesions Often First Sign of Mpox Infection in 2022 Outbreak

39 percent of patients had fewer than five lesions; papules, vesicles, pustules predominated in first five days of infection

By Dermsquared Editorial Team | May 10, 2023

Dupilumab Beneficial for Adults With Prurigo Nodularis

All primary and key secondary end points met in two phase 3 trials of adults with PN with ≥20 nodules

By Elana Gotkine (HealthDay News) | May 10, 2023

Mindfulness, Self-Compassion Training Improves QOL in Eczema

Intervention group showed greater improvement in Dermatology Life Quality Index score at 13 weeks and in secondary end points

By Elana Gotkine (HealthDay News) | May 10, 2023

Electromagnetic Field Technology Plus Radiofrequency Cuts Visceral Adipose Tissue

High-intensity focused electromagnetic field technology with radiofrequency reduces VAT at three months; reduction maintained at six months

By Dermsquared Editorial Team | May 10, 2023

Adalimumab Plus Surgery Better for Hidradenitis Suppurativa

Greater reduction seen in International HS Severity Score System and in Dermatology Life Quality Index in combination group

By Dermsquared Editorial Team | May 05, 2023

Convolution Neural Network Aids Diagnosis for Melanocytic Lesions by Dermatologists

The most diagnostic improvement was seen for dermatologists with less dermoscopy experience cooperating with the CNN

By Dermsquared Editorial Team | May 05, 2023

CDC Reports No New Mpox Cases in Over a Week for First Time Since Outbreak Began

Since the outbreak began last May, more than 30,000 people have been infected with the virus and 42 people have died

By Physician's Briefing Staff | May 05, 2023

New Model Helps ID Melanoma Patients With Lymph Node Involvement

Patient-centered methodology-generated probabilities better identify patients eligible for sentinel lymph node biopsy than those generated by conventional logistic regression analysis

By Elana Gotkine (HealthDay News) | May 05, 2023

Nearby Nature Does Not Protect Against Early Childhood Eczema

Exposure to coniferous, mixed forests and agriculture areas associated with elevated eczema risk

By Lori Solomon (HealthDay News) | May 05, 2023

Child With Psoriasis Negatively Impacts Mom's Quality of Life

Positive association seen between mothers' Family Dermatology Life Quality Index scores and children's Psoriasis Area Severity Index scores

By Elana Gotkine (HealthDay News) | April 28, 2023

Good Agreement Found for Clinical, Photograph Assessment of Psoriasis

Intraclass correlation coefficient 0.78 between clinical and photographic Psoriasis Area and Severity Index

By Elana Gotkine (HealthDay News) | April 28, 2023

Anti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma

Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support

By Elana Gotkine (HealthDay News) | April 28, 2023

Chronic Hand Eczema Rapidly Improves With Gusacitinib

Significant reductions seen over placebo for 80 mg gusacitinib in mTLSS, PGA, HECSI as early as week 2

By Dermsquared Editorial Team | April 28, 2023

Validity Demonstrated for Hidradenitis Suppurativa Investigator Global Assessment

Tool has good psychometric properties compared with existing measures

By Dermsquared Editorial Team | April 28, 2023

Is Model With SLN Status Effective in Predicting Melanoma-Specific Death?

Model estimating five-year MSD risk that includes sentinel lymph node status provides greater net benefits across treatment thresholds

By Dermsquared Editorial Team | April 05, 2023

Does Vitamin D Supplementation Impact Psoriasis Severity?

No difference seen in change in PASI score, Physician Global Assessment score, self-administered PASI, Dermatology Life Quality Index

By Dermsquared Editorial Team | April 05, 2023

Risk for Melanoma Reduced for Individuals With Atopy

Fewer cases of melanoma, lower investigator-estimated risk class of skin cancer observed in atopic versus nonatopic individuals

By Elana Gotkine (HealthDay News) | March 31, 2023

AAD: Nemolizumab Beneficial for Patients With Prurigo Nodularis

Improvement seen in primary and key secondary end points, including peak pruritus numerical rating scale, sleep disturbance

By Dermsquared Editorial Team | March 29, 2023

AAD: Long-Term Efficacy Seen for Baricitinib in Alopecia Areata

39.1 percent of baricitinib 4-mg-treated patients with SALT score >20 at week 52 achieved SALT score ≤20 by week 104

By Dermsquared Editorial Team | March 29, 2023

Promising Results Seen for Bimekizumab in Hidradenitis Suppurativa

Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50

By Elana Gotkine (HealthDay News) | March 29, 2023

Long-Term Improvement Seen With Ruxolitinib in Vitiligo

Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104

By Elana Gotkine (HealthDay News) | March 28, 2023

Risk for Skin Cancer Higher for Adults With Atopic Dermatitis

Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis

By Elana Gotkine (HealthDay News) | March 27, 2023

Topical Lovastatin Aids Disseminated Superficial Actinic Porokeratosis

Disease severity decreased by about 50 percent in the lovastatin-cholesterol and lovastatin-alone treatment groups

By Dermsquared Editorial Team | March 22, 2023

Hispanic Patients More Likely to Have Melanoma Diagnosed at Stage IV

Significant differences seen for insurance status, income, education, Charlson-Deyo score, stage for Hispanic, White patients

By Dermsquared Editorial Team | March 22, 2023

Smoking Independently Tied to Higher Risk for Psoriasis

However, based on genetic analysis, smoking may not be a causal factor of psoriasis

By Lori Solomon (HealthDay News) | March 21, 2023

Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients

No difference seen in keratinocyte cancers or actinic keratoses for organ-transplant recipients receiving oral nicotinamide or placebo

By Elana Gotkine (HealthDay News) | March 17, 2023

No Benefit Seen for Plasmapheresis First After Corticosteroids for SJS/TEN

Medical costs, LOS higher with plasmapheresis first versus intravenous immunoglobulin first for Stevens-Johnson syndrome and toxic epidermal necrolysis

By Dermsquared Editorial Team | March 15, 2023

Can AI Tool Improve Quality of Patient-Submitted Images of Skin Disease?

Patient use of machine learning algorithm led to reduction in number of patients with poor-quality images

By Dermsquared Editorial Team | March 15, 2023

Hair Regrowth Seen in Alopecia With Methotrexate Prednisone

About 31 percent of patients with recalcitrant alopecia areata totalis or universalis had complete hair regrowth

By Elana Gotkine (HealthDay News) | March 15, 2023

Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma

Event-free survival longer for those receiving neoadjuvant and adjuvant pembrolizumab versus adjuvant pembrolizumab only

By Physician's Briefing Staff | March 10, 2023

Is Paroxetine Efficacious, Safe for Erythema of Rosacea?

Significantly greater proportion of patients achieved Clinical Erythema Assessment success with paroxetine versus placebo

By Dermsquared Editorial Team | March 08, 2023

Microneedling, 5FU, Excimer Promising for Nonsegmental Vitiligo

Combination of 5FU after microneedling and excimer more suitable for localized, focal vitiligo

By Dermsquared Editorial Team | March 08, 2023

Most Patients Like Having Access to Dermatology Clinic Notes

Concerns were few and included not understanding notes or abbreviations

By Lori Solomon (HealthDay News) | March 08, 2023

Burden of Alopecia Areata Significant in the United States

Standardized prevalence highest in those aged 30 to 39, 40 to 49 years; Asians, Blacks, Hispanic/Latinos have increased prevalence ratios

By Elana Gotkine (HealthDay News) | March 06, 2023

Prevalence of Alopecia Areata Increased From 2016 to 2019 in the United States

Prevalence and incidence higher for females versus males, adults versus children and teens, in Northeast versus other regions

By Dermsquared Editorial Team | March 01, 2023

2005 to 2015 Saw Increase in Prevalence of Total Body Skin Exams

Only race/ethnicity with increase was non-Hispanic Whites; increases seen for those aged 31 to 40, 51 to 64 years

By Dermsquared Editorial Team | March 01, 2023

Psoriasis Tied to Elevated Risk for Celiac Disease

People with psoriasis have double the odds of celiac disease versus people without psoriasis

By Lori Solomon (HealthDay News) | February 28, 2023

AAAAI: Black Children With Eczema More Likely to Have Asthma

Black children with asthma less likely to have seen an allergist, more likely to lack prior inhalant allergy testing

By Elana Gotkine (HealthDay News) | February 27, 2023

Methotrexate Linked to Increased Risk for Skin Cancer

When restricting analysis to patients with psoriasis, methotrexate was only associated with basal cell carcinoma

By Elana Gotkine (HealthDay News) | February 23, 2023

1997 to 2018 Saw Increase in Prevalence of Eczema in Children

Average annual percentage change of prevalence was lower in White versus Black and multiracial children

By Dermsquared Editorial Team | February 22, 2023

Headline from the Week of May 22-28, 2023

Is Tirbanibulin Effective for Treating Actinic Keratosis?

By Dermsquared Editorial Team | May 24, 2023

Do Patients With Melasma Have Lower Levels of Serum Vitamin D?

By Dermsquared Editorial Team | May 24, 2023